Back to Search
Start Over
863P A phase I study of mirvetuximab soravtansine (MIRV) and gemcitabine (G) in pts with selected FRĪ± -positive solid tumours: Results in the endometrial cancer (EC) cohort.
- Source :
-
Annals of Oncology . 2020 Supplement 4, Vol. 31, pS639-S639. 1p. - Publication Year :
- 2020
- Subjects :
- *ENDOMETRIAL cancer
*GEMCITABINE
*TUMORS
Subjects
Details
- Language :
- English
- ISSN :
- 09237534
- Volume :
- 31
- Database :
- Academic Search Index
- Journal :
- Annals of Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 152695537
- Full Text :
- https://doi.org/10.1016/j.annonc.2020.08.1002